메뉴 건너뛰기




Volumn 21, Issue 5, 2010, Pages 1599-1604

Development of bisphosphonates controlled delivery systems for bone implantation: Influence of the formulation and process used on in vitro release

Author keywords

[No Author keywords available]

Indexed keywords

APATITE; CALCIUM PHOSPHATE; EMULSIFICATION; MICROENCAPSULATION; TARGETED DRUG DELIVERY;

EID: 77954534483     PISSN: 09574530     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10856-010-4012-x     Document Type: Article
Times cited : (8)

References (15)
  • 1
    • 0029926353 scopus 로고    scopus 로고
    • Adverse effects of bisphosphonates. A comparative review
    • Adami S, Zamberlan N. Adverse effects of bisphosphonates. A comparative review. Drug Saf. 1996;14:158-170
    • (1996) Drug Saf , vol.14 , pp. 158-170
    • Adami, S.1    Zamberlan, N.2
  • 2
    • 3042796964 scopus 로고    scopus 로고
    • Bisphosphonates: New therapeutic agents for the treatment of bone tumors
    • Heymann D, Ory B, Gouin F, Green JR, Redini F. Bisphosphonates: new therapeutic agents for the treatment of bone tumors. Trends Mol Med. 2004;10:337-343
    • (2004) Trends Mol Med , vol.10 , pp. 337-343
    • Heymann, D.1    Ory, B.2    Gouin, F.3    Green, J.R.4    Redini, F.5
  • 3
    • 66049130260 scopus 로고    scopus 로고
    • In vitro osteogenesis of synovium stem cells induced by controlled release of bisphosphate additives from microspherical mesoporous silica composite
    • Shi X, Wang Y, Varshney RR, Ren L, Zhang F, Wang D-A. In vitro osteogenesis of synovium stem cells induced by controlled release of bisphosphate additives from microspherical mesoporous silica composite. Biomaterials. 2009;30(23-24):3996-4005.
    • (2009) Biomaterials , vol.30 , Issue.23-24 , pp. 3996-4005
    • Shi, X.1    Wang, Y.2    Varshney, R.R.3    Ren, L.4    Zhang, F.5    Wang, D.-A.6
  • 4
    • 2442597362 scopus 로고    scopus 로고
    • Pharmacokinetic and clinical equivalence of oral and intravenous ibandronate for metastatic bone disease
    • Leyland-Jones B. Pharmacokinetic and clinical equivalence of oral and intravenous ibandronate for metastatic bone disease. Eur J Cancer Suppl. 2004;2(5):9-12.
    • (2004) Eur J Cancer Suppl , vol.2 , Issue.5 , pp. 9-12
    • Leyland-Jones, B.1
  • 5
    • 0041826905 scopus 로고    scopus 로고
    • Safety of subcutaneous clodronate and efficacy in hypercalcemia of malignancy: A novel route of administration
    • Roemer-Bécuwe C, Vigano A, Romano F, Neumann C, Hanson J, Quan HK, et al. Safety of subcutaneous clodronate and efficacy in hypercalcemia of malignancy: a novel route of administration. J Pain Symptom Manag. 2003;26(3):843-848
    • (2003) J Pain Symptom Manag , vol.26 , Issue.3 , pp. 843-848
    • Roemer-Bécuwe, C.1    Vigano, A.2    Romano, F.3    Neumann, C.4    Hanson, J.5    Quan, H.K.6
  • 6
    • 0345868772 scopus 로고    scopus 로고
    • Surface immobilized bisphosphonate improves stainless-steel screw fixation in rats
    • Tengvall P, Skoglundb B, Askendala A, Aspenbergb P. Surface immobilized bisphosphonate improves stainless-steel screw fixation in rats. Biomaterials. 2004;25:2133-2138
    • (2004) Biomaterials , vol.25 , pp. 2133-2138
    • Tengvall, P.1    Skoglundb, B.2    Askendala, A.3    Aspenbergb, P.4
  • 7
    • 53749087447 scopus 로고    scopus 로고
    • Implants delivering bisphosphonate locally increase periprosthetic bone density in an osteoporetic sheep model. A pilot study
    • Stadelmann VA, Gauthier O, Terrier A, Bouler JM, Pioletti DP. Implants delivering bisphosphonate locally increase periprosthetic bone density in an osteoporetic sheep model. A pilot study. Eur Cells Mater. 2008;16:10-16
    • (2008) Eur Cells Mater , vol.16 , pp. 10-16
    • Stadelmann, V.A.1    Gauthier, O.2    Terrier, A.3    Bouler, J.M.4    Pioletti, D.P.5
  • 8
    • 0032806886 scopus 로고    scopus 로고
    • Biphasic calcium phosphate/hydrosoluble polymer composites: A new concept for bone and dental substitution biomaterials
    • Daculsi G, Weiss P, Bouler JM, Gauthier O, Millot F, Aguado E. Biphasic calcium phosphate/hydrosoluble polymer composites: a new concept for bone and dental substitution biomaterials. Bone. 1999;25(2):59S-61S.
    • (1999) Bone , vol.25 , Issue.2
    • Daculsi, G.1    Weiss, P.2    Bouler, J.M.3    Gauthier, O.4    Millot, F.5    Aguado, E.6
  • 9
    • 58549091279 scopus 로고    scopus 로고
    • Enhancing alendronate release from a novel PLGA/hydroxyapatite microspheric system for bone repairing applications
    • Shi X, Wang Y, Ren L, Gong Y, Wang D-A. Enhancing alendronate release from a novel PLGA/hydroxyapatite microspheric system for bone repairing applications. Pharm Res. 2009;26:422-430
    • (2009) Pharm Res , vol.26 , pp. 422-430
    • Shi, X.1    Wang, Y.2    Ren, L.3    Gong, Y.4    Wang, D.-A.5
  • 10
    • 19444369850 scopus 로고    scopus 로고
    • Chemically modified calcium phosphates as novel materials for bisphosphonate delivery
    • Josse S, Faucheux C, Soueidan A, Grimandi G, et al. Chemically modified calcium phosphates as novel materials for bisphosphonate delivery. Adv Mater. 2004;16(16):1423-1427
    • (2004) Adv Mater , vol.16 , Issue.16 , pp. 1423-1427
    • Josse, S.1    Faucheux, C.2    Soueidan, A.3    Grimandi, G.4
  • 11
    • 62249156240 scopus 로고    scopus 로고
    • Controlled release of bisphosphonate from a calcium phosphate biomaterial inhibits osteoclastic resorption in vitro
    • Faucheux C, Verron E, Soueidan A, Josse S, Arshad MD, Janvier P, et al. Controlled release of bisphosphonate from a calcium phosphate biomaterial inhibits osteoclastic resorption in vitro. J Biomed Mater Res. 2009;89A:46-56.
    • (2009) J Biomed Mater Res , vol.89 , pp. 46-56
    • Faucheux, C.1    Verron, E.2    Soueidan, A.3    Josse, S.4    Arshad, M.D.5    Janvier, P.6
  • 12
    • 0033992223 scopus 로고    scopus 로고
    • Isostatic compression, a new process for incorporating vancomycin into biphasic calcium phosphate: Comparison with a classical method
    • Gautier H, Merle C, Auget JL, Daculsi G. Isostatic compression, a new process for incorporating vancomycin into biphasic calcium phosphate: comparison with a classical method. Biomaterials. 2000;21:243-249
    • (2000) Biomaterials , vol.21 , pp. 243-249
    • Gautier, H.1    Merle, C.2    Auget, J.L.3    Daculsi, G.4
  • 13
    • 31544455022 scopus 로고    scopus 로고
    • Vancomycin biodegradable poly(lactide-co-glycolide) microparticles for bone implantation. Influence of the formulation parameters on the size, morphology, drug loading and in vitro release
    • Billon A, Chabaud L, Gouyette A, Bouler JM, Merle C. Vancomycin biodegradable poly(lactide-co-glycolide) microparticles for bone implantation. Influence of the formulation parameters on the size, morphology, drug loading and in vitro release. J Microencapsul. 2005;22(8):841-852
    • (2005) J Microencapsul , vol.22 , Issue.8 , pp. 841-852
    • Billon, A.1    Chabaud, L.2    Gouyette, A.3    Bouler, J.M.4    Merle, C.5
  • 15
    • 0343879238 scopus 로고
    • Assay of inorganic phosphate, total phosphate and phosphatases
    • In: Colowick SP, Kaplan NO, Orlando: Academic Press
    • Ames BN. Assay of inorganic phosphate, total phosphate and phosphatases. In: Colowick SP, Kaplan NO, editors. Methods in enzymology, vol.8. Orlando: Academic Press; 1966. p. 115-118
    • (1966) Methods in Enzymology , vol.8 , pp. 115-118
    • Ames, B.N.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.